App aims to lift depression in stressed med students
NCT ID NCT07397299
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a mental health app called Intellect can reduce depression and improve resilience in medical students. 220 students will be split into two groups: one gets full app access, the other gets basic access. Researchers will check changes in mood, anxiety, and self-esteem after three months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Intellect: Create A Better You mental health app
- What this could lead to
- If it works, this could provide an accessible, low-cost tool to help medical students manage depression and build resilience.
- What could go wrong
- This is a small, early-stage study with only 220 participants. The app may not outperform basic support, and results may not apply to other groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fakulti Perubatan, Universiti Kebangsaan Malaysia
Cheras, Kuala Lumpur, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who returns to work after stress treatment?
- Can a Parent-Targeted program ease Kids' behavior problems when depression is in the picture?
- A Two-Year watch: can brain scans and surveys predict depression and anxiety in teens?
- Can a Three-Session therapy rival CBT for Event-Related depression?
- Your genes could hold the key to better depression treatment
- A therapy that aims to boost wellbeing, not just ease symptoms — a trial puts it to the test